The associate professor at The Ohio State University Comprehensive Cancer Center explained the goals for the future of the CAR T-cell therapy data in patients with DLBCL.
Samantha Jaglowski, MD, MPH
Advertisement
Articles by Samantha Jaglowski, MD, MPH
The associate professor at The Ohio State University Comprehensive Cancer Center discussed the implications of her analysis of the CAR T-cell therapy tisagenlecleucel for patients with diffuse large B-cell lymphoma at the ASH Annual Meeting & Exposition.
Advertisement
Latest Updated Articles
Samantha Jaglowski, MD, MPH, Discusses Implications of Tisagenlecleucel for Patients with DLBCLPublished: December 16th 2019 | Updated:
Samantha Jaglowski, MD, MPH, on Next Steps Regarding Tisagenlecleucel for Patients with DLBCLPublished: January 9th 2020 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
3
64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC
4
FDA Grants Fast Track Designation to NG-350A For pMMR Rectal Cancer
5
